HIGHLIGHTS
- who: Santiago Duro-Su00e1nchez and colleagues from the , Barcelona, Spain have published the article: Immunotherapies against HER2-Positive Breast Cancer, in the Journal: Cancers 2023, 15, 1069. of 28/Dec/2022
- what: In this review the authors examine the different immunotherapeutic strategies being tested in from long-studied vaccines to immune checkpoint blockade which targets immune checkpoints in both T cells and tumor cells as well as the promising adoptive cell therapy in various forms. The authors discuss how some of these new approaches may contribute to the prevention of tumor progression and be used . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.